NCT04774874View on ClinicalTrials.gov

A Phase 2a Trial of FOL-005 Topical Formulations to Investigate Hair Growth Potential and Safety in Healthy Male Volunteers

PHASE2CompletedINTERVENTIONAL
Enrollment

209

Participants

Timeline

Start Date

June 24, 2020

Primary Completion Date

January 29, 2021

Study Completion Date

January 29, 2021

Conditions
Androgenetic Alopecia
Interventions
DRUG

Topical formulation

Topical administration on the scalp once daily for 16 weeks

Trial Locations (1)

Unknown

ProDerm GmbH, Hamburg

Sponsors

Lead Sponsor

Follicum AB
All Listed Sponsors
collaborator

proDERM GmbH

INDUSTRY

collaborator

Hair and Skin Institute, Charité, Berlin, Germany

UNKNOWN

collaborator

CentroDerm GmbH

NETWORK

lead

Follicum AB

INDUSTRY

NCT04774874 - A Phase 2a Trial of FOL-005 Topical Formulations to Investigate Hair Growth Potential and Safety in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter